Preclinical to market (drug development I) 01

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/15

encourage image

There's no tags or description

Looks like no tags are added yet.

16 Terms

1
New cards

Major activities of drug development (preclinical stage)

- Pharmacology

- Determining safety

- Developing formulation

2
New cards

Safety testing I (in vitro)

1. Extensive in vitro safety

2. Goal: "clean" safety profile

3. Identify potential "deal-breakers" early

<p>1. Extensive in vitro safety</p><p>2. Goal: "clean" safety profile</p><p>3. Identify potential "deal-breakers" early</p>
3
New cards

1. Extensive in vitro safety (safety testing I)

- Biochem & cell-based analysis

- May be performed internally or outsourced to CROs

<p>- Biochem & cell-based analysis </p><p>- May be performed internally or outsourced to CROs</p>
4
New cards

2. "Clean" safety profile (safety testing I)

- Few significant safety liabilities

- Undesired effects ideally occur above expected therapeutic exposure

<p>- Few significant safety liabilities</p><p>- Undesired effects ideally occur above expected therapeutic exposure</p>
5
New cards

3. Identify potential "deal breakers" early (safety testing I)

- Cyto+genotoxicity

- Undesired effects on important biolo systems

<p>- Cyto+genotoxicity</p><p>- Undesired effects on important biolo systems</p>
6
New cards

Safety testing II (in vivo)

- Evaluate safety in a whole living organism

- Follow 3Rs replace, reduce, refine

- Select scientifically appropriate species

- Toxicology studies include non+rodents

7
New cards

Evaluate... (safety testing II)

- Dose/exposure-toxicity relationships

- Target organs of toxicity

- Reversibility of adverse effects

8
New cards

Formulation

- Converts drug candidate into suitable dosage form

- Combines active pharmaceutical ingredient (API) w appropriate excipients

- Ex: tablets, capsules

9
New cards

The formulation is designed to provide...

- Accurate & consistent dosing

- Stability

- Ease of administration

10
New cards

Excipients

- Inactive ingredients added to a formulation for specific functions

- Common ones: preservatives, colouring agents

<p>- Inactive ingredients added to a formulation for specific functions</p><p>- Common ones: preservatives, colouring agents</p>
11
New cards

Types of formulation

- Topical: creams

- Injectable: IV

- Transdermal: patches

- Inhaled: powders

- Oral: tablets

<p>- Topical: creams</p><p>- Injectable: IV </p><p>- Transdermal: patches</p><p>- Inhaled: powders</p><p>- Oral: tablets</p>
12
New cards

Process chemistry

- Establish methods for large-scale synth

- Develop practical purification methods: crystallization, etc.

- Optimize process: safety, cost, NRG use

- Goal: safe, reproducible, efficient process w consistent purity, quality & impurity profile

13
New cards

Documentation

- Development studies require planning & documentation

- Maintain accurate & traceable records

- Reg, legal & safety errors = consequences

- Relevant data support reg. submissions

14
New cards

Patent protection

- Protects intellectual property (IP)

- May cover drug & related inventions

- Scope of protection dep on patent claims

15
New cards

Patent is a form of intellectual property

- Gives patent owner legal right to exclude others from practicing claimed invention

- Protection for limited period

- May cover: formulations, manufacturing process

16
New cards

Patent requirements

1. Novelty: new & not previously disclosed invention

2. Utility: specific & useful purpose

3. Non-obviousness: not an obvious development by a person "skilled in art"